- 209863-09-2[1,1'-Biphenyl]-4-carboxaldehyde,3'-methoxy-
- 20986-40-73-Pyridinecarboxylicacid, 5-bromo-, ethyl ester
- 2098-66-03'H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione,6-chloro-1,2-dihydro-17-hydroxy-, (1b,2b)-
- 20989-17-7(S)-(+)-2-Phenylglycinol
- 209909-03-53-Quinolinemethanol,2-chloro-6,7-difluoro-
- 209909-13-73-Quinolinecarboxaldehyde,2-chloro-6,7-difluoro-
- 209909-88-6D-Ribose-1,2-13C2 (9CI)
- 209911-63-7[1,1'-Biphenyl]-2-carbonitrile,4'-(dibromomethyl)-
- 209912-44-7Benzoicacid, 4-(3-methyl-1,2,4-oxadiazol-5-yl)-, methyl ester
- 209917-48-6Benzenesulfonamide,4-amino-N-(1,1-dimethylethyl)-
Hot Products
- 70458-92-3Pefloxacin
- 6809-52-55,9,13,17-Nonadecatetraen-2-one,6,10,14,18-tetramethyl-
- 92-55-75-Nitro-2-furaldehyde diacetate
- 88-45-9Benzenesulfonic acid,2,5-diamino-
- 106-86-51,2-Epoxy-4-vinylcyclohexane
- 9005-49-6Heparin
- 13048-33-42-Propenoic acid,1,1'-(1,6-hexanediyl) ester
- 941678-49-5Ruxolitinib
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Tafluprost |
EINECS | N/A |
| CAS No. | 209860-87-7 | Density | 1.186 g/cm3 |
| PSA | 75.99000 | LogP | 4.68300 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C25H34F2O5 | Boiling Point | 552.9ºC at 760mmHg |
| Molecular Weight | 452.539 | Flash Point | 288.2°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
5-Heptenoicacid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]-3,5-dihydroxycyclopentyl]-,1-methylethyl ester, (5Z)- (9CI);AFP 168;5-Heptenoic acid,7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-,1-methylethyl ester, (5Z)-;MK-2452; |
Article Data | 17 |
Tafluprost Specification
Tafluprost, with the IUPAC Name of Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-3-phenylmethoxyprop-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate, is one kind of analogue. Tafluprost(CAS NO.209860-87-7) is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.
Physical properties about Tafluprost are: (1)ACD/LogP: 3.829; (2)ACD/LogD (pH 5.5): 3.83; (3)ACD/LogD (pH 7.4): 3.83; (4)ACD/BCF (pH 5.5): 478.85; (5)ACD/BCF (pH 7.4): 478.85; (6)ACD/KOC (pH 5.5): 2884.63; (7)ACD/KOC (pH 7.4): 2884.63; (8)#H bond acceptors: 5; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 15; (11)Index of Refraction: 1.549; (12)Molar Refractivity: 121.342 cm3; (13)Molar Volume: 381.518 cm3; (14)Polarizability: 48.104 10-24cm3; (15)Surface Tension: 40.7639999389648 dyne/cm; (16)Density: 1.186 g/cm3; (17)Flash Point: 288.21 °C ; (18)Enthalpy of Vaporization: 87.722 kJ/mol; (19)Boiling Point: 552.943 °C at 760 mmHg
You could convert the following datas into the molecular structure:
(1)InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1;
(2)InChIKey=WSNODXPBBALQOF-VEJSHDCNSA-N
What can I do for you?
Get Best Price
